RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections.

about

RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections.

Item

http://www.wikidata.org/entity/Q55454646

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@en

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@nl

type

Item

label

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@en

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@nl

prefLabel

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@en

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@nl

P1476

RIG-I-Like Receptors as Novel ...... Re-Emerging Viral Infections.

@en

P2093

Hui Yee Yong

http://www.w3.org/2001/XMLSchema#string

P2860

MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades

Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice

Immune signaling by RIG-I-like receptors

Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses

P304

1379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01379

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dahai Luo

P577

2018-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29973930

http://www.w3.org/2001/XMLSchema#string

P932

6019452

http://www.w3.org/2001/XMLSchema#string